Femoro-Popliteal Angioplasty and Stenting

Table of Contents


1. Executive Summary

2. State of the Science

2.1 Peripheral Artery Disease (PAD)

2.1.1 Epidemiology
2.1.2 Diagnosis
2.1.3 Management

2.2 Interventional Procedures

2.2.1 Angioplasty
2.2.2 Stenting
2.2.3 Other Interventional Modalities

2.3 Surgical Procedures

2.3.1 Bypass Surgery
2.3.2 Endarterectomy
2.3.3 Amputation

2.4 Clinical Trials Update

3. State of the Technology

3.1 Angioplasty
3.2 Stenting
3.3 Stent Grafts
3.4 Drug Eluting Stents
3.5 Atherectomy
3.6 Cryoplasty
3.7 Laser Therapy
3.8 Brachytherapy

4. Companies & Their Products

4.1 Abbott
4.2 AngioDynamics
4.3 B. Braun
4.4 Biotronics
4.5 Boston Scientific
4.6 Cardiatis
4.7 Cook Group
4.8 Cordis
4.9 C. R. Bard
4.10 CryoVascular Systems
4.11 Edwards Lifesciences
4.12 EV3
4.13 Foxhollow Technologies
4.14 Gore Medical
4.15 IDev Technologies
4.16 Medtronic
4.17 Minow Medical
4.18 Spectranetics
4.19 Terumo
4.20 Vascular Architects

5. Current Market Situation

5.1 Target Market
5.2 Market Size & Growth Rates
5.3 Leading Companies Market Shares

6. Market Forecast

6.1 Market Opportunity
6.2 Market Potential
6.3 Market Forecast